Viewing data from:

PIMTREA

ANDA

DESOGESTREL; ETHINYL ESTRADIOL | A091247 | NOVAST LABORATORIES LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: CYCLESSA(TE code: AB)

Medicare Part D Spending

CMS annual spending data for Pimtrea (2023)

Total Spending

$7K

Total Claims

168

Beneficiaries

Avg Cost/Unit

$0.84

Spending Trend

$31K(2019)→$28K(2020)→$22K(2021)→$13K(2022)→$7K(2023)

YoY Change:-14.9%

5yr CAGR:-5.2%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 0.15MG,N/A;0.02MG,0.01MG

0 patents0 exclusivities▴

TABLET;ORAL-28 | Approved: Aug 1, 2013

No patent or exclusivity listings for this strength.